Data / Form D filings / NuSirt Sciences Inc.
NuSirt Sciences Inc.: Form D filings
NuSirt Sciences Inc., a pharmaceuticals company in Nashville, TN, filed 3 Form D notices with the SEC between 2015 and 2016. The latest, on December 1, 2016, reports $2 million sold of a $2 million offering to 29 investors.
Find out what NuSirt Sciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3835 CLEGHORN AVENUE SUITE 200, Nashville, TN, 37215
- Phone
- (615) 656-7898
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1642239
The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 1, 2016 | New notice | $1,999,997 | $1,999,997 | $0 | 29 | Nov 22, 2016 | sec.gov |
| Oct 13, 2015 | New notice | $8,000,142 | $4,000,071 | $4,000,071 | 28 | Sep 30, 2015 | sec.gov |
| May 14, 2015 | New notice | $6,000,000 | $2,070,000 | $3,930,000 | 26 | May 7, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian C. Laden | Director | |
| Vaughn C. Bryson | Director | |
| Joseph C. Cook, Jr. | Executive Officer, Director | |
| Eric C. Satz | Director | |
| Michael C. Zemel | Executive Officer, Director | |
| Barbara Cannon | Executive Officer |
Every Form D from the week of Nov 28, 2016 · All recent filings in Tennessee · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NuSirt Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.